Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
Stopped early · Phase 3
Conditions studied: Prostate Cancer
In brief
RATIONALE: Ultrasound therapy kills tumor cells by heating them to several degrees above body temperature. This treatment may be effective for prostate cancer. PURPOSE: Phase III trial to determine the effectiveness of ultrasound therapy in treating patients who have stage I or stage II prostate cancer that has recurred following radiation therapy.
Key facts
- Study ID
- NCT00005075
- Run by
- EDAP Technomed
- Starts
- 1999-07-01
- Last updated by the study team
- 2013-11-06
Who can join
Age: 50 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- Baylor College of Medicine — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.